Erectile Dysfunction Treatment Market Analysis 2019 Top companies are Pfizer Inc, Bayer AG, Eli Lilly and Company, APRICUS BIOSCIENCES, INC
Erectile dysfunction treatment market is growing at a substantial CAGR in the forecast period of 2020-2027. This rise in market value can be attributed to the high incidence rate of chronic diseases including hypertension, neurogenic and psychological disorders are some factors responsible for the market growth of erectile dysfunction drugs.
Key Market Players:
The key market players in the erectile dysfunction treatment market are Pfizer Inc, Bayer AG, Eli Lilly and Company, APRICUS BIOSCIENCES, INC, Mylan N.V, VIVUS Inc, DONG-A SOCIO HOLDINGS., Amgen Inc, GlaxoSmithKline plc, Tissue Genesis, Sanofi, PHARMICELL Co., Ltd, SK chemicals, Rexahn Pharmaceuticals, Inc, ALLERGAN, JW Holdings among others.
Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-erectile-dysfunction-treatment-market
Competitive Analysis:
Erectile dysfunction treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of erectile dysfunction treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Global Erectile Dysfunction Treatment Market By Type (Low-Flow or Ischemic Priapism and High-Flow or Non-Ischemic Priapism), Treatment (Medications, Surgery, Psychological Counseling, Penis Pumps, Penile Implants, Others), Drugs (Sildenafil, Tadalafil, Vardenafil, Avanafil and Others, Route of Administration (Oral, Intravenous and Others), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2027
Market Outlook: Global Erectile Dysfunction Treatment Market
Erectile dysfunction is a type of sexual dysfunction which is characterized by, when a patient unable to attain or maintain a penile erection during a sexual activity. The cause of this condition is decreased blood flow due to narrowing of the blood vessels, which supply blood to the penis. This disorder can cause stress, affects self-confidence of the patient and contribute to relationship problems and can also be a sign of heart diseases. Certain medications such as vardenafil, tadalafil and sildenafil are prescribed for this condition but these medications have serious side effects on the vision of eye such as blurry vision, light sensitivity, difficulty in differentiating colors such as blue and green apart, having a blue-green tinge to your vision and decreased color vision.
Market Drivers:
- Ongoing clinical trial conducted by many pharmaceuticals companies is driving the market growth
- Rising aged population worldwide is accelerating the market growth
- Sedentary lifestyle and increasing habit of alcoholism and smoking is acting as catalyst to market growth
- Growing number of campaigns by government and non-government organizations worldwide to make patients aware of the disease is boosting the market growth
Market Restraints:
- Patent expiry of some major drugs is hindering the market growth for erectile dysfunction treatment market
- Shrinking insurance coverage for erectile dysfunction treatment is hampering the market growth
- Increasing manufactures of generic drugs is restraining the market growth
- Availability of counterfeit drugs may restrict the market growth in the forecast period
Grab Your Report at an Impressive 30% Discount! Please click Here@https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-erectile-dysfunction-treatment-market
Global Erectile Dysfunction Treatment Market Scope and Market Size:
Erectile dysfunction treatment market is segmented of the basis of types, treatment, drugs, route of administration, distribution channel and end user. The growth among these specific segments will help users analyze niche pockets of growth and strategies to approach the market and determine your core application areas and difference in your target markets.
Based on types, the erectile dysfunction treatment market is segmented low-flow or ischemic priapism and high-flow or non-ischemic priapism
Based on treatment, the erectile dysfunction treatment market is segmented as medications, surgery, psychological counseling, penis pumps, penile implants and others
Based on drugs, the erectile dysfunction treatment market is segmented as sildenafil, tadalafil, vardenafil, avanafil and others
Based on the route of administration, the erectile dysfunction treatment market is segmented into oral, intravenous and others
Based on the distribution channel, the erectile dysfunction treatment market is segmented as direct, online pharmacy, retailers and others
Based on end-users, the erectile dysfunction treatment market is segmented into hospitals, homecare, specialty clinics and others
Global Erectile Dysfunction Treatment Market Country Level Analysis
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, Rest of Middle East and Africa as a part of Middle East and Africa, Argentina, Brazil, Peru and Rest of South America as part of South America.
Key Developments in the Market
- In June 2019, Futura Medical plc is developing MED2005, a topical glyceryl trinitrate (GTN) gel to treat erectile dysfunction. This drug is currently ongoing in phase lll clinical trial. If approved, it will be the fastest-acting erectile dysfunction treatment
- In January 2019, Pharmicell Co., Ltd is developing Cellgram-ED (mesenchymal stem cell) for the treatment of impotency associated with erectile dysfunction, currently in phase l clinical trial. If approved this novel drug treatment will provide the potential treatment for patients suffering from erectile dysfunction.
Table Of Content: Erectile Dysfunction Treatment Market
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Erectile Dysfunction Treatment Market
Part 04: Global Erectile Dysfunction Treatment Market Sizing
Part 05: Global Erectile Dysfunction Treatment Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Continue. .
For Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-erectile-dysfunction-treatment-market
Reasons to Purchase this Report:
- Current and future of global erectile dysfunction treatment market outlook in the developed and emerging markets.
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
- The latest developments, market shares, and strategies that are employed by the major market players.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]
